You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 14, 2025

Drugs Containing Excipient (Inactive Ingredient) MICROCRYSTALLINE CELLULOSE 102


✉ Email this page to a colleague

« Back to Dashboard


Branded drugs containing MICROCRYSTALLINE CELLULOSE 102 excipient, and estimated key patent expiration / generic entry dates

Generic drugs containing MICROCRYSTALLINE CELLULOSE 102 excipient

Market Dynamics and Financial Trajectory for Microcrystalline Cellulose 102

Introduction to Microcrystalline Cellulose 102

Microcrystalline cellulose (MCC) 102 is a refined form of cellulose characterized by its shorter crystalline polymer chains. It is widely used as an excipient in various industries, particularly in pharmaceuticals, food, and cosmetics. Here, we delve into the market dynamics and financial trajectory of MCC 102, highlighting its key applications, growth drivers, and future outlook.

Applications of Microcrystalline Cellulose 102

Pharmaceutical Industry

MCC 102 plays a crucial role in the pharmaceutical industry as an excipient. It is valued for its excellent binding, disintegration, and flow properties, which enhance the efficacy of tablets and capsules. MCC acts as a filler, disintegrant, bulking agent, binder, and lubricant in drug formulations, making it an essential component in the development of new and innovative drug delivery systems[3][4][5].

Food and Beverages

In the food industry, MCC 102 is used as a fat replacer and stabilizer in low-calorie and gluten-free products. Its ability to improve texture and stability makes it a popular choice for processed foods, contributing significantly to its market growth[3][4].

Cosmetics and Personal Care

MCC 102 is also utilized in the cosmetics and personal care sector due to its stabilizing and thickening properties. It is often incorporated into skincare products, hair care products, and other personal care items[4][5].

Market Growth Drivers

Rising Demand in Pharmaceuticals

The growing global pharmaceutical industry is a significant driver of the MCC 102 market. With projected global spending on medicines expected to reach $1.8 trillion by 2026, the demand for high-quality excipients like MCC 102 is set to increase. The rise of personalized medicine and the need for more efficient drug delivery systems further fuel this demand[3].

Increasing Health Awareness and Consumer Preferences

The increasing preference for processed foods, particularly low-calorie and gluten-free products, in regions like North America, drives the demand for MCC 102. Consumers seeking convenient and health-oriented products are contributing to the sustained growth of the MCC market[3][4].

Population Growth and Urbanization

The growing population in regions such as the Asia Pacific, projected to rise to 5.2 billion by 2050, creates a substantial demand for food and pharmaceutical products. This population growth, combined with increasing disposable incomes, is expected to lead to higher consumption of products where MCC 102 is used[3].

Financial Trajectory

Global Market Valuation

The global microcrystalline cellulose market was valued at USD 1.38 billion in 2024 and is projected to reach USD 2.46 billion by 2031, growing at a CAGR of 8.24%. This significant growth is driven by the versatile applications of MCC across various industries[3].

North America Market

In North America, the MCC market is expected to grow at a CAGR of 7.4%, reaching over USD 1,058 million by 2032. This region dominates the global MCC market due to its strong pharmaceutical sector and the rising demand for processed foods[1].

Global Market Size by 2032

The global microcrystalline cellulose market size is expected to reach USD 2,095.05 million by 2032, according to Polaris Market Research. This growth is attributed to the increasing demand from pharmaceutical, food, and cosmetic industries[4].

Market Dynamics

Competitive Landscape

The MCC market is characterized by a competitive landscape with several key players. The market is driven by innovation and the expansion of manufacturing capacity, which is expected to positively impact the overall efficiency of the supply chain and stimulate market growth[5].

Regulatory Environment

The regulatory environment plays a crucial role in the MCC market. Compliance with regulatory standards, such as those set by the U.S. Food and Drug Administration (FDA), is essential for the use of MCC in pharmaceutical and food products. The consistent increase in new drug approvals by the FDA highlights the expanding pharmaceutical landscape and directly drives the demand for MCC[3].

Innovations and Market Expansion

Innovative Drug Development

Innovative drug development is expected to significantly promote the pharmaceuticals segment of the MCC market. MCC’s unique properties make it a crucial excipient in formulation processes, and its ability to enhance tablet disintegration, improve drug solubility, and act as a binding agent drives its demand in novel drug formulations[3].

Market Expansion in Emerging Regions

The growing population and increasing disposable incomes in emerging regions, such as the Asia Pacific, are expected to lead to higher consumption of products where MCC 102 is used. This population growth and urbanization are key factors driving market expansion in these regions[3].

Key Takeaways

  • Growing Pharmaceutical Industry: The increasing global spending on medicines and the rise of personalized medicine are driving the demand for MCC 102.
  • Versatile Applications: MCC 102 is used in pharmaceuticals, food, and cosmetics, making it a crucial component across various industries.
  • Regional Dominance: North America dominates the global MCC market due to its strong pharmaceutical sector and rising demand for processed foods.
  • Financial Growth: The global MCC market is projected to reach USD 2.46 billion by 2031, growing at a CAGR of 8.24%.
  • Innovations and Expansion: Innovative drug development and market expansion in emerging regions are key drivers of the MCC 102 market.

FAQs

What are the primary applications of microcrystalline cellulose 102?

Microcrystalline cellulose 102 is primarily used as an excipient in the pharmaceutical industry, as a fat replacer and stabilizer in the food industry, and as a stabilizing and thickening agent in cosmetics and personal care products.

How is the growing pharmaceutical industry impacting the MCC 102 market?

The growing pharmaceutical industry is significantly fueling the demand for MCC 102 due to its essential roles in enhancing tablet compressibility, stability, and bioavailability, and its use in novel drug formulations and delivery systems.

What is the projected market size of the global microcrystalline cellulose market by 2032?

The global microcrystalline cellulose market is expected to reach USD 2,095.05 million by 2032, according to Polaris Market Research.

Why is North America a dominant region in the MCC 102 market?

North America dominates the global MCC market due to its strong pharmaceutical sector and the rising demand for processed foods, which are key drivers of the MCC 102 market.

How does population growth impact the demand for MCC 102?

The growing population, particularly in regions like the Asia Pacific, combined with increasing disposable incomes, leads to higher consumption of food and pharmaceutical products, thereby driving the demand for MCC 102.

Sources

  1. Polaris Market Research, "North America Microcrystalline Cellulose Market Hits $1.06B by 2032".
  2. CNAUCO, "High Quality 102 Microcrystalline Cellulose".
  3. Verified Market Research, "In-Depth Industry Outlook: Microcrystalline Cellulose Market Size – 2024-2031".
  4. Polaris Market Research, "Global Microcrystalline Cellulose Market Size, Share, Trends, Industry Analysis Report".
  5. Persistence Market Research, "Microcrystalline Cellulose Market Size & Share Report, 2030".

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.